Back to search
Lung Squamous Cell Carcinoma Stage IV
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lung Squamous Cell Carcinoma Stage IV trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Lung Squamous Cell Carcinoma Stage IV trials you may qualify forThis phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that h…
This phase IV trial is evaluating whether morning versus afternoon administration of standard of care immunotherapy impacts its effectiveness in treating patien…
The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in particip…
Efficacy and Safety of Sacituzumab Tirumotecan Combined with Furmonertinib in Patients with Locally Advanced or Metastatic Non-squamous Non-Small Cell Lung Canc…
This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembr…
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease i…
This phase II trial studies how well low dose, reduced frequency nivolumab works in treating patients with cancer that cannot be removed by surgery (unresectabl…
This study intends to carry out prospective, randomized controlled clinical trials in many centers across the country to compare the efficacy and safety of immu…